TRANS-1-(TERT-BUTOXYCARBONYL)-4-(P-TOLYL)PYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 1g

3-ethyl 5-methyl 2-[(2-aminoethoxy)methylidene]-4-(2-chlorophenyl)-6-methyl-1,2,3,4-tetrahydropyridine-3,5-dicarboxylate, 97%, 25g

[3-(benzyloxy)-1-(hydroxymethyl)cyclobutyl]methanol, 95.0%, 10g

(S)-2-(2,6,7,8-TETRAHYDRO-1H-INDENO[5,4-B]FURAN-8-YL)ETHANAMINE HCL, 97%, 500mg

2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-yl 4-methylbenzenesulfonate, 98%, 1g

4-Hydroxypiperidine-1-carboxylic acid isopropyl ester, 95.0%, 25g

NBD-COCl [=4-(N-Chloroformylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole] [for HPLC Labeling]>92.0%(T)100mg

Methyl 1,6-naphthyridine-2-carboxylate, 95.0%, 5g

4-(2-Fluoro-3-nitrophenyl)pyridine, 98%, 1g

(4R)-2-[2-(DIPHENYLPHOSPHINO)PHENYL]-4,5-DIHYDRO-4-(PHENYLMETHYL)OXAZOLE, 95%, 1g

(2R,3R,4R,5S)-6-(Octylamino)hexane-1,2,3,4,5-pentanol, 95.0%, 500g

3H-Imidazo[4,5-b]pyridine-6-carboxylic acid, 95.0%, 100mg

1,1-Cyclobutanedicarboxylic acid, 99.0%, 100g